Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $752.44 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Averitas Pharma Inc. | $241.18 | 10 | $0 (2024) |
| AbbVie Inc. | $113.83 | 5 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $84.94 | 4 | $0 (2022) |
| Lilly USA, LLC | $60.80 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $36.62 | 2 | $0 (2022) |
| Amgen Inc. | $35.97 | 2 | $0 (2022) |
| PFIZER INC. | $33.25 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $27.65 | 2 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $23.58 | 1 | $0 (2024) |
| Exact Sciences Corporation | $17.30 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $204.34 | 10 | Averitas Pharma Inc. ($180.76) |
| 2023 | $262.48 | 12 | AbbVie Inc. ($90.26) |
| 2022 | $256.61 | 14 | Biohaven Pharmaceutical Holding Company Ltd. ($84.94) |
| 2021 | $29.01 | 2 | Otsuka America Pharmaceutical, Inc. ($16.86) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/10/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $3.42 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/21/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $23.58 | General |
| Category: Opioid Analgesic | ||||||
| 07/31/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: PAIN MANAGEMENT | ||||||
| 07/31/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/07/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/18/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $73.82 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/22/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/30/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/18/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/01/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $60.42 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/16/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: VACCINES | ||||||
| 05/18/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Neuroscience | ||||||
| 04/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/29/2023 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: VACCINES | ||||||
| 03/23/2023 | Medtronic, Inc. | MINIMED 770G (Device) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Durable Pump | ||||||
| 03/09/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Oncology | ||||||
| 02/10/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Neuroscience | ||||||
| 01/05/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Cardio-renal | ||||||
| 12/07/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Diabetes | ||||||
| 12/05/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 189 | 229 | $49,079 | $18,561 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 31 | $12,191 | $4,139 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 50 | $10,173 | $3,568 | 35.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 51 | $7,366 | $3,106 | 42.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $7,074 | $2,606 | 36.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $3,396 | $1,838 | 54.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 37 | $5,016 | $1,662 | 33.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 19 | $3,862 | $1,642 | 42.5% |
About John Ward
John Ward is a Hospice and Palliative Medicine healthcare provider based in Belpre, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2020. The National Provider Identifier (NPI) number assigned to this provider is 1063040434.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Ward has received a total of $752.44 in payments from pharmaceutical and medical device companies, with $204.34 received in 2024. These payments were reported across 38 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($752.44).
As a Medicare-enrolled provider, Ward has provided services to 189 Medicare beneficiaries, totaling 229 services with total Medicare billing of $18,561. Data is available for 1 year (2023–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Hospice and Palliative Medicine
- Location Belpre, OH
- Active Since 03/31/2020
- Last Updated 02/17/2025
- Taxonomy Code 207QH0002X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063040434
Products in Payments
- QUTENZA (Drug) $241.18
- QULIPTA (Drug) $113.83
- NURTEC ODT (Drug) $84.94
- EMGALITY (Drug) $60.80
- JARDIANCE (Drug) $36.62
- EVENITY (Biological) $35.97
- FARXIGA (Drug) $27.65
- Belbuca (Drug) $23.58
- Cologuard Collection Kit (Device) $17.30
- Kerendia (Drug) $17.04
- COMIRNATY (Biological) $16.96
- REXULTI (Drug) $16.86
- MINIMED 770G (Device) $16.59
- PREVNAR 13 (Biological) $16.29
- Lenvima (Drug) $14.83
- Ozempic (Drug) $12.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.